Primary prevention of dementia
Symptomatic treatments that work by enhancing neurotransmitter function have been available for several years, and are generally accepted as being modestly beneficial in about 50% of those for whom they are prescribed. Disease-modifying drugs that may prevent or retard neuronal deterioration are bei...
Auteur principal: | Wilcock, G |
---|---|
Format: | Book section |
Publié: |
2004
|
Documents similaires
-
Methodological issues in primary prevention trials for neurodegenerative dementia.
par: Andrieu, S, et autres
Publié: (2009) -
Dementia with Lewy bodies.
par: Wilcock, G
Publié: (2003) -
The ageing brain and dementia.
par: Wilcock, G
Publié: (1981) -
Memantine for the treatment of dementia.
par: Wilcock, G
Publié: (2003) -
A review of dementia.
par: Wilcock, G
Publié: (1982)